The abstract is read at the publisher; the summary is JClub's.
AMP-410, a VEGF-4-1BB conditional bifunctional antibody, drives sustained tumor-local macrophage and Pex T-cell activation in human 4-1BB transgenic mice.
- Why it matters: Systemic 4-1BB agonism risks limiting therapeutic window due to widespread immune activation and liver inflammation, while checkpoint approaches may not fully engage durable innate–adaptive immunity.
- What they did: In human 4-1BB transgenic mice with syngeneic MC38 colorectal carcinoma or B16F10 melanoma, AMP-410 was evaluated for macrophage differentiation, Pex T-cell signatures, clonal tumor T-cell expansion, and later-stage persistence.
- The result: AMP-410 promoted rapid M1 macrophage differentiation and enhanced Pex signatures, then sustained macrophage antitumor activity and continued Pex expansion, indicating long-term tumor-local immune engagement.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.